Shares of CVS Health Corporation (NYSE:CVS – Get Free Report) reached a new 52-week high on Wednesday . The company traded as high as $98.61 and last traded at $98.1440, with a volume of 4587487 shares traded. The stock had previously closed at $97.06.
CVS Health News Roundup
Here are the key news stories impacting CVS Health this week:
- Positive Sentiment: CVS was included in a Zacks screen of low price-to-book stocks that combine discounted valuation with projected long-term EPS growth, which may reinforce the bullish case for shares. 5 Low Price-to-Book Stocks That Are Worth Buying in June
- Positive Sentiment: Another Zacks note said CVS is trading at a 52-week high, suggesting momentum is strong and investors are watching to see whether the rally can continue. CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue?
- Positive Sentiment: CVS Health has also been labeled a trending stock by Zacks, which can add to near-term trading attention and support shares. CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
- Positive Sentiment: Aetna launched “Mental Health on Demand,” which gives members real-time access to care and may help improve CVS’s consumer health and insurance positioning. CVS Health: Aetna Launches Aetna Mental Health on Demand To Provide Real Time Access to Care and Ongoing Support
- Positive Sentiment: CVS is using Fluency’s AI platform to push autonomous agents into production, signaling continued investment in automation and operating efficiency. CVS is Using Fluency to Close Enterprise AI Deployment Gap
- Neutral Sentiment: CVS executives also discussed efforts to use AI and technology to reduce administrative burdens and improve care delivery, but the piece was more strategic than a direct financial catalyst. Healthy Returns: CVS Health executives on reducing health care’s biggest pain points
- Neutral Sentiment: CVS and Mass General Brigham are moving closer to a primary care partnership, which could be strategically helpful but is still in development. Mass General Brigham and CVS primary care partnership moves closer to reality
- Neutral Sentiment: Musab Balbale’s departure and interim merchandising leadership changes appear operational rather than clearly material to near-term earnings. Musab Balbale Departs CVS Health
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of CVS Health in a research report on Friday, May 8th. DA Davidson raised their price target on shares of CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Wall Street Zen upgraded CVS Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. JPMorgan Chase & Co. raised their price objective on CVS Health from $101.00 to $111.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 12th. Finally, TD Cowen raised their price objective on CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Twenty-two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $100.68.
CVS Health Price Performance
The company has a 50 day moving average of $86.32 and a 200-day moving average of $80.63. The stock has a market capitalization of $129.98 billion, a P/E ratio of 44.88, a PEG ratio of 0.96 and a beta of 0.62. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78.
CVS Health (NYSE:CVS – Get Free Report) last posted its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.21 by $0.36. The company had revenue of $100.43 billion for the quarter, compared to analysts’ expectations of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The firm’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period last year, the business posted $2.25 earnings per share. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Sell-side analysts predict that CVS Health Corporation will post 7.44 EPS for the current year.
CVS Health Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Thursday, April 23rd. CVS Health’s dividend payout ratio (DPR) is presently 117.18%.
Insiders Place Their Bets
In other CVS Health news, EVP Tilak Mandadi sold 69,551 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the sale, the executive vice president directly owned 10,133 shares in the company, valued at approximately $907,714.14. This trade represents a 87.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Larry Robbins sold 370,462 shares of the firm’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $93.45, for a total value of $34,619,673.90. Following the completion of the sale, the director owned 4,824,799 shares in the company, valued at $450,877,466.55. The trade was a 7.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 3,441,551 shares of company stock worth $323,703,977 over the last quarter. 0.85% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On CVS Health
A number of hedge funds have recently added to or reduced their stakes in the stock. Sei Investments Co. increased its holdings in shares of CVS Health by 17.4% during the second quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator’s stock valued at $62,474,000 after purchasing an additional 134,535 shares during the period. The Manufacturers Life Insurance Company increased its holdings in shares of CVS Health by 1.2% during the second quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator’s stock valued at $77,353,000 after purchasing an additional 13,329 shares during the period. Treasurer of the State of North Carolina increased its holdings in shares of CVS Health by 1.3% during the second quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator’s stock valued at $40,358,000 after purchasing an additional 7,588 shares during the period. HUB Investment Partners LLC increased its holdings in shares of CVS Health by 25.0% during the second quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator’s stock valued at $1,039,000 after purchasing an additional 3,011 shares during the period. Finally, Alliancebernstein L.P. increased its holdings in shares of CVS Health by 8.0% during the second quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator’s stock valued at $111,017,000 after purchasing an additional 119,439 shares during the period. 80.66% of the stock is currently owned by institutional investors.
About CVS Health
CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.
Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.
Featured Articles
- Five stocks we like better than CVS Health
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
